ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

MDNA Medicenna Therapeutics Corp

2.49
0.00 (0.00%)
29 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Medicenna Therapeutics Corp MDNA 토론토 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 2.49 20:32:02
개장가 저가 고가 종가 전일 종가
2.49
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
26/04/202421:16PRNCAL'Organisme canadien de réglementation des investissements..
26/04/202421:14PRNCACanadian Investment Regulatory Organization Trade Resumption..
26/04/202421:09PRNCASuspension de la négociation par l'Organisme canadien de..
26/04/202421:07PRNCACanadian Investment Regulatory Organization Trading Halt -..
26/04/202421:00GLOBEMedicenna Therapeutics Announces CA$20 Million Investment..
24/04/202423:05GLOBEMedicenna Announces Oral Presentation of MDNA11 Data from..
10/04/202419:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
10/04/202405:30GLOBEMedicenna Presents Updated Results of Single Agent MDNA11..
10/04/202401:01GLOBEMedicenna Presents Updated Preclinical Data on MDNA113, a..
04/04/202420:00GLOBEMedicenna to Present at the 2024 Bloom Burton & Co...
06/03/202421:00GLOBEMedicenna to Provide Clinical Update on the MDNA11 ABILITY-1..
14/02/202421:30GLOBEMedicenna Therapeutics Reports Third Quarter Fiscal 2024..
13/02/202421:00GLOBEMedicenna Announces First Patient Dosed in ABILITY-1 Study..
13/01/202407:36GLOBEMedicenna Announces Appointment of New Auditor
09/01/202421:00GLOBEMedicenna Commences Enrollment in the ABILITY-1 Study..
22/12/202309:30GLOBEMedicenna Extends Period to Exercise Certain Warrants
19/12/202321:00GLOBEMedicenna Announces Trading on the OTCQB Under the Symbol..
14/11/202322:30GLOBEMedicenna Therapeutics Reports Second Quarter Fiscal 2024..
09/11/202322:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
06/11/202321:00GLOBEMedicenna Announces Promising Single-Agent Response and..
04/11/202301:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
27/10/202320:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
25/10/202320:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
24/10/202320:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10/10/202320:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
03/10/202320:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
29/09/202306:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
28/09/202320:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
06/09/202320:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
28/08/202320:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
14/08/202320:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
08/08/202320:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
04/08/202320:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
01/08/202322:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
28/07/202320:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
25/07/202320:00GLOBEMedicenna Presents at National Brain Tumor Society's..
05/07/202320:00GLOBEMedicenna Extends Period to Exercise Certain Warrants
27/06/202321:00GLOBEMedicenna Reports Fiscal Year 2023 Financial Results and..

최근 히스토리

Delayed Upgrade Clock